A large body of published work shows that proton (hydrogen 1 [1H]) magnetic resonance
(MR) spectroscopy has evolved from a research tool into a clinical neuroimaging modality …

Localized proton magnetic resonance spectroscopy (MRS) of the human brain, first reported
more than 20 years ago, 1–3 is a mature methodology that is used clinically in many medical …

Proton nuclear magnetic resonance (1H NMR) spectroscopy is a noninvasive technique that
can provide information on a wide range of metabolites. Marked abnormalities of 1H NMR …

Localized 1H NMR spectroscopy in conjunction with J editing was used to measure the
concentration of gamma-aminobutyric acid (GABA) in the occipital lobe of four control …

Proton spectroscopy can noninvasively provide useful information on brain tumor type and
grade. Short‐(30 ms) and long‐(136 ms) echo time (TE) 1H spectra were acquired from …

Following the impetus of early clinical and experimental investigations, in vivo and in vitro
MRS studies of tumours pointed in the eighties to the possible significance of signals arising …

The literature describing 31P, 1H, 13C, 23Na and 19F MRS in vivo in human cancers is
reviewed. Cancers have typical metabolic characteristics in 31P and 1H MRS including high …

Magnetic resonance (MR) spectroscopy has received little attention from the clinical
radiology community. Indeed, most MR spectroscopic studies are performed by a small and …

Diagnosis of primary and secondary brain tumours and other focal intracranial mass lesions
based on imaging procedures alone is still a challenging problem. Proton magnetic …

Magnetic resonance spectroscopy (MRS) and the related technique of magnetic resonance
spectroscopic imaging (MRSI) are widely used in both clinical and preclinical research for …